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Introduction
Involvement of the testes - one of the most common
sites of relapse in Acute Lymphoblastic Leukemia (ALL) usually presents with painless enlargement of one or both
testes. Testicular involvement occurs in 10% to 23% of
boys during the course of the disease at a median time of
13 months from diagnosis. Occult testicular involvement
is recognized in 10% to 33% of boys undergoing
bilateral wedge biopsies performed during the first 3
years of treatment or any time after cessation of the
therapy (1). In a study in which biopsies were done in
boys with newly diagnosed ALL, microscopic testicular
involvement was reported to be 21% (2).
Since the clinical incidence of testicular relapse varies
widely from l to 40%, and since microscopic infiltrates in
autopsies have been reported to be 64 to 92% in boys, it
is suggested that testicular infiltration escapes clinical
detection until the organ is several times its normal size
(2).
In light of these data, testicular infiltration was
evaluated by testicular ultrasonography (USG) and biopsy
and the correlation analyses between these methods were
carried out in a group of boys with ALL followed up at Dr.
Behçet Uz Children’s Hospital.
Among 154 ALL patients, 25 boys aged between 2
and 14 years, followed up at Dr. Behçet Uz Children’s
Hospital between 1985 and 1996 were included in the
study. Seventeen undewent testicular USG and biopsy just
after the cessation of the therapy, whereas in 8 boys
these procedures were performed whenever clinical
involvement was suspected. Testicular biopsies were
performed as bilateral open wedge biopsies and were
evaluated histologically.

Ten of the 17 patients were in the standard (SRG), 5
were in the intermediate (MRG) and 2 were in the high
risk group (HRG). UKALL, BFM 90 and LSA2L2 treatment
regimens were given to these patients. Remission
induction therapy and radiotherapy at 18 Gy were given
to all of the patients according to the UKALL therapy
protocol.
All of the subjects were evaluated clinically. Eight boys
having painless testicular enlargement underwent
testicular USG and biopsy immediately. All cases were
evaluated in light of the clinical, ultrasonographic and
biopsy findings. Specifity, sensitivity, positive predictivity
and negative predictivity values were detected.
In 17 cases with no clinical evidence of testicular
involvement, USG revealed a hypoechoic area in one, and
a metastatic mass image in another. However their
biopsies showed no pathology histologically.
Therapy was completed in all of these 17 cases.
Fourteen cases are still at the follow-up stage lasting 6
months to 8 years. Two cases were not part of the follow
up by the end of the first year after the cessation of their
therapy. One case died due to hepatitis B infection
although he had been vaccinated.
Testicular USG and biopsy findings were evaluated in
8 cases with painless testicular enlargement. In 8 cases in
which testicular infiltration was suspected according to
the ultrasonographic findings, 3 cases showed no
evidence of infiltration at the biopsy.
Risk groups, time of involvement and the results are
summarized in table 1.
Four cases showing testicular infiltration were in the
HRG. Except one case, time for testicular relapse varied
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Case

Risk Groups

Time of relapse

The other relapses

Results

1

HRG

6 months after

Bone Marrow

In remission. At

diagnosis

(BM)

follow-up stage for 1.5

1 year after the

-

Table 1.

Risk groups, time of testicular
involvement and the results of
the cases with testicular
infiltration

years
2

MRG

Follow up discontinued
after 1 year

therapy
3

HRG

1 year after

CNS+BM

Exitus

diagnosis
4

HRG

At the diagnosis

BM

In remission. At
follow-up stage for 1
year

5

HRG

1 year after

-

In remission. At

diagnosis

follow-up stage for 2
year

between 6 months and one years. Remission was
achieved in all of the cases by residue BFM 90 ALL
therapy protocol. Radiotherapy at 18 Gy was given in
addition to chemotherapy. Hematologic relapse occurred
in one case one month after the remission and he died
during the induction therapy. The other two cases were
at the follow-up stage for 1 to 2 years. Contact with one
case was lost after 1 year follow up.
Testes are the second common site of relapse in boys
with ALL. Testicular relapse may be the first recognized
site for recurrent leukemias. In the study of Stoffel and
coworkers, testicular involvement was the first site of
relepsa in 8 out of 13 patients (67%) (3). Overt disease
is most often seen within 2 years of stopping therapy,
irrespective of the duration of the therapy (1). Incidence
of testicular relapse is different in different studies (4-9).
In our study, none of our 17 patients in whom
biopsies were performed after the cessation of the
therapy, showed pathologic findings and testicular relapse
did not occur during the followup. Five of the 8 cases
with evidence of clinical testicular involvement had also
microscopic evidence of testicular disease. Thus, testicular

biopsy may be a more valuable method if it is performed
whenever involvement is suspected clinically. Frequent
and detailed testicular examination, evaluation of their
size and hardness should be preferred to routine biopsies.
Testicular USG was performed on all of the cases
before the biopsy, and the clinical findings,
ultrasonographic and biopsy results were compared. Eric
et al. compared the clinical, USG, magnetic resonance
(MR) and biopsy findings in 8 cases. USG and MR results
were negative in all cases, but 4 cases showed leukemic
infiltration in biopsy. This study suggested that USG and
MR were not successful in evaluating the presence of
testicular involvement (10). In our study, the specifity for
the positivity of clinical findings and biopsy was 85%,
sensitivity was 100%, the positive predictive value was
62.5% and the negative predictive value was 100%.
When the relationship between USG and biopsy was
evaluated; sensitivity, specifity, positive predictivity and
negative predictivity values were 100%, 75%, 50% and
100% respectively. According to these results we
conclude that if there is clinical suspicion of testicular
involvement, it is appropriate to perform testicular biopsy
directly without an ultrasonographic examination.
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